Zhengye Biotechnology Holding (ZYBT) Balance Sheet: Assets & Liabilities

Zhengye Biotechnology Holding (ZYBT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Zhengye Biotechnology Holding reported total assets of CNY 436.47M and total liabilities of CNY 129.76M. Shareholders' equity was CNY 249.85M, down 12.0% from CNY 283.96M a year earlier. Total debt stood at CNY 75.08M against CNY 51.89M in cash and short-term investments, a net debt position of CNY 23.19M. That puts debt-to-equity at 0.30, compared with 0.30 a year earlier.

Zhengye Biotechnology Holding Balance Sheet Analysis

Values in millions CNY

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Zhengye Biotechnology Holding Limited (ZYBT) - Annual data in millions CNY
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Jun 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	50.33	18.60	18.60	15.07	9.75	6.28
Short-Term Investments	1.56	1.43	1.43	1.22	0.00	0.00
Cash & Short-Term Investments	51.89	20.04	20.04	16.30	9.75	6.28
Accounts Receivable	18.49	88.52	59.56	74.17	133.58	83.42
Inventory	39.17	58.22	58.22	58.30	55.42	43.62
Other Current Assets	27.88	10.79	19.40	31.57	14.89	12.85
Total Current Assets	137.42	177.57	177.57	189.24	214.31	164.94
Non-Current Assets
Property, Plant & Equipment (Net)	237.28	255.16	255.16	263.25	275.23	246.41
Intangible Assets	54.76	22.78	22.78	24.48	27.90	20.75
Other Non-Current Assets	7.01	26.75	37.74	6.50	2.23	13.17
Total Non-Current Assets	299.05	315.68	315.68	310.65	305.37	280.34
Total Assets	436.47	493.25	493.25	499.89	519.67	445.28
Current Liabilities
Accounts Payable	44.01	42.96	42.96	45.66	79.28	77.57
Short-Term Debt	65.91	81.63	81.63	79.86	54.89	30.00
Current Portion of Long-Term Debt	0.70	-	7.19	-	-	-
Accrued Liabilities	3.46	-	0.10	0.01	3.46	0.31
Deferred Revenue	4.83	3.69	3.69	3.99	4.60	4.28
Other Current Liabilities	3.39	5.56	0.56	0.84	10.00	0.87
Total Current Liabilities	120.48	135.91	135.91	150.23	152.23	125.63
Non-Current Liabilities
Long-Term Debt	9.18	4.80	4.80	9.99	9.99	0.00
Deferred Tax Liabilities	0.10	0.00	-	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	-	0.39	0.59	0.82
Total Non-Current Liabilities	9.28	4.80	4.80	10.38	10.58	0.82
Total Liabilities	129.76	140.71	140.71	160.62	162.81	126.44
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Retained Earnings	-21.63	48.15	48.15	38.38	65.77	42.33
Accumulated Other Comprehensive Income	30.72	32.65	32.65	31.31	27.57	21.99
Additional Paid-in Capital	240.75	203.15	203.15	203.15	203.15	203.15
Minority Interest	56.87	68.58	68.58	66.42	60.37	51.36
Shares Outstanding	47.39	-	47.17	47.17	47.17	47.17
Total Stockholders' Equity	249.85	283.96	283.96	272.85	356.87	267.47
Total Liabilities & Equity	436.47	493.25	493.25	499.89	519.67	445.28

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Zhengye Biotechnology Holding Balance Sheet

How much debt does Zhengye Biotechnology Holding have?

Zhengye Biotechnology Holding had total debt of CNY 75.08M as of Dec 31, 2025, against CNY 51.89M in cash and short-term investments. Its debt-to-equity ratio was 0.30. Total debt was CNY 86.43M a year earlier.

What are Zhengye Biotechnology Holding's total assets?

Zhengye Biotechnology Holding reported total assets of CNY 436.47M as of Dec 31, 2025, down 11.5% from CNY 493.25M a year earlier. Total liabilities were CNY 129.76M.

What is Zhengye Biotechnology Holding's shareholders' equity?

Zhengye Biotechnology Holding's shareholders' equity was CNY 249.85M as of Dec 31, 2025, or about CNY 5.27 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition